Recombinant Spider Silk–Silica Hybrid Scaffolds with Drug-Releasing Properties for Tissue Engineering Applications

Titelangaben

Kumari, Sushma ; Bargel, Hendrik ; Scheibel, Thomas:
Recombinant Spider Silk–Silica Hybrid Scaffolds with Drug-Releasing Properties for Tissue Engineering Applications.
In: Macromolecular Rapid Communications. Bd. 41 (Januar 2020) Heft 1 . - S. 1900426.
ISSN 1521-3927
DOI der Verlagsversion: https://doi.org/10.1002/marc.201900426

Volltext

	Format: PDF Name: marc.201900426.pdf Version: Veröffentlichte Version Verfügbar mit der Lizenz Creative Commons BY-NC-ND 4.0: Namensnennung, nicht kommerziell, keine Bearbeitung
	Download (2MB)

Abstract

Fabricating biomaterials with antimicrobial activity to prevent the growth of detrimental microorganisms is of great scientific and practical interest. Here, composite materials comprising recombinant spider silk proteins and mesoporous silica nanoparticles (MSN) loaded with selected antibiotics and antimycotics are fabricated into films and hydrogels. The derived composite materials exhibit excellent antimicrobial properties with sustained release of antibiotics over the course of 15 days. Furthermore, antibiotics/antimycotics inclusion does not impair the cytocompatibility of the composite materials, all of which promote fibroblast cell adhesion and proliferation. Finally, processing of spider silk–MSN composite hydrogels using 3D printing is shown to enable the fabrication of patient‐specific antimicrobial implants to prevent infection in the near future.